Oxford Cannabinoid Technologies Holdings (OCTP) RNS Announcements

Add to Alert list
Date Time Source Announcement
08 Mar 2022 08:26 PM
EQS
Data from pre-clinical study of OCT461201 shows...
08 Mar 2022 07:00 AM
RNS
Data from pre-clinical study show positive results
04 Mar 2022 01:00 PM
RNS
Requisition of General Meeting - Update
03 Mar 2022 04:41 PM
RNS
Second Price Monitoring Extn
03 Mar 2022 04:36 PM
RNS
Price Monitoring Extension
22 Feb 2022 07:00 AM
RNS
Interim Results: 6 months to 30 November 2021
18 Feb 2022 05:15 PM
RNS
Requisition of General Meeting
07 Feb 2022 07:00 AM
RNS
Notice of Interim Results & Investor Presentations
31 Jan 2022 07:00 AM
RNS
Board Changes
24 Jan 2022 04:36 PM
RNS
Price Monitoring Extension
18 Jan 2022 07:00 AM
RNS
Trading Update & Change of Accounting Year-End
07 Jan 2022 04:40 PM
RNS
Second Price Monitoring Extn
07 Jan 2022 04:35 PM
RNS
Price Monitoring Extension
15 Dec 2021 02:06 PM
RNS
Second Price Monitoring Extn
15 Dec 2021 02:00 PM
RNS
Price Monitoring Extension
02 Dec 2021 02:11 PM
RNS
Holding in Company
02 Dec 2021 02:09 PM
RNS
Holding in Company
02 Dec 2021 07:00 AM
RNS
Director Dealings
01 Dec 2021 07:00 AM
RNS
Admission to Trading on the US OTC QB Market
30 Nov 2021 05:00 PM
RNS
Corporate Adviser Change
29 Nov 2021 04:41 PM
RNS
Second Price Monitoring Extn
29 Nov 2021 04:36 PM
RNS
Price Monitoring Extension
24 Nov 2021 05:06 PM
RNS
Directorate Change
24 Nov 2021 03:35 PM
RNS
Result of AGM
23 Nov 2021 07:00 AM
RNS
New Agreement with Dalriada Drug Discovery Inc.
17 Nov 2021 07:00 AM
RNS
New Agreement signed with Oxford Stemtech Limited
11 Nov 2021 07:00 AM
RNS
Director Dealing Update
05 Nov 2021 01:35 PM
RNS
Director Dealing Update & Board Changes
01 Nov 2021 07:00 AM
RNS
Director Dealing
27 Oct 2021 07:00 AM
RNS
Posting of Annual Report & Notice of AGM
26 Oct 2021 07:00 AM
RNS
Appointment of North American IR Adviser
13 Oct 2021 07:00 AM
RNS
2021 Final Results and Notice of AGM
11 Oct 2021 07:00 AM
RNS
New Partnerships Targeting Trigeminal Neuralgia
23 Sep 2021 04:21 PM
RNS
Rescheduling of Final Results Announcement
22 Sep 2021 07:00 AM
RNS
Exclusive Agreement with Canopy Growth Corporation
23 Aug 2021 07:00 AM
RNS
Pre-Close Trading Update & Notice of Final Results
28 Jul 2021 07:00 AM
RNS
Post IPO Review & Notice of Trading Update
06 Jul 2021 07:00 AM
RNS
Service Agreement with Drug Development Company
25 Jun 2021 08:14 AM
RNS
Holding(s) in Company
04 Jun 2021 03:33 PM
RNS
Holding(s) in Company
04 Jun 2021 03:20 PM
RNS
Holding(s) in Company
04 Jun 2021 07:00 AM
RNS
Company Presentation Webinar to Retail Investors
01 Jun 2021 07:00 AM
RNS
Consultancy Agreement with Voisin Consulting SARL
28 May 2021 07:00 AM
RNS
Total Voting Rights
25 May 2021 10:13 AM
RNS
Holding(s) in Company
25 May 2021 09:05 AM
RNS
Holding(s) in Company
24 May 2021 05:32 PM
RNS
Holding(s) in Company
21 May 2021 07:00 AM
RNS
Admission to Trading and First Day of Dealings

Oxford Cannabinoid Technologies Holdings is a clinical stage biopharmaceutical company focused on the development and commercialisation of innovative cannabinoid medicines. In May 2024 it announced that it applied to the Financial Conduct Authority and London Stock Exchange plc to effect a cancellation of listing of its ordinary shares on the Standard segment of the FCA's Official List and trading on the Main Market for listed securities of the LSE.

Oxford Cannabinoid Technologies Holdings was listed in London under the ticker OCTP.

UK 100

Latest directors dealings